Cryo-Cell International
CCEL
14 hedge funds and large institutions have $6.82M invested in Cryo-Cell International in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
5% more capital invested
Capital invested by funds: $6.52M → $6.82M (+$303K)
0.53% more ownership
Funds ownership: 10.54% → 11.07% (+0.53%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$181K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.4K |
| 3 |
BlackRock
New York
|
+$1.71K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$472 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$389 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$9.77K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.14K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$216 |
CCEL Hedge Fund Activity: Q2 2024 in Review
14 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q2 2024, worth a combined $6.82M — up 4.7% from $6.52M a quarter earlier.
Fund positioning in CCEL was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $181K. The largest seller was Northern Trust, cutting an estimated $9.77K.
- 14 institutional investors held Cryo-Cell International (CCEL) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $6.82M of Cryo-Cell International stock for Q2 2024, up 4.7% quarter-over-quarter.
- 1 fund opened new Cryo-Cell International positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Cryo-Cell International buyer in Q2 2024 was Vanguard Group, an estimated $181K added.
- The largest Cryo-Cell International seller in Q2 2024 was Northern Trust, an estimated $9.77K sold.
Based on aggregated 13F filings for Q2 2024.